Scipher Medicine Corp

WALTHAM, MA · Founded 2013 · Biotech · Acquired

AI-powered precision immunology platform for patient-to-therapy matching

Claim this profile

Follows are private to you and power your alerts

Updated · sciphermedicine.com

Sector
Biotech
Headquarters
WALTHAM, MA
Founded
2013
Latest Form D
$5.8M, Jul 2024
Total capital
$118M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$118M
7 Form D · last Jul 2024
27 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20152017201920212023FEDERAL ↑EQUITY ↓Cumulative $118M3rd Form D$795K5th Form D$20M6th Form D$82M7th Form D$5.8M
20152017201920212023FEDERAL ↑EQUITY ↓Cumulative $118M6th Form D$82M

Latest events

  • Private capital raisedForm D · SEC · 7th filing$5.8M
  • Private capital raisedForm D · SEC · 6th filing$82M
  • Private capital raisedForm D · SEC · 5th filing$20M
  • Private capital raisedForm D · SEC · 4th filing$8.5M
  • Private capital raisedForm D · SEC · 3rd filing$795K
  • Private capital raisedForm D · SEC · 2nd filing$575K
  • Private capital raisedForm D · SEC · 1st filing$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Albert Laszlo BarabasiDirectorNamed in SEC Form D filings
  • ALBERT-LASZLO BARABASIDirectorNamed in SEC Form D filings
  • Alif SalehExecutive Officer, DirectorNamed in SEC Form D filings
  • Byron KalogerouExecutive OfficerNamed in SEC Form D filings
  • GLENN MUIRDirectorNamed in SEC Form D filings
  • INGO CHAKRAVARTYDirectorNamed in SEC Form D filings
Show all 14 people
  • Jeffrey SachsExecutive OfficerNamed in SEC Form D filings
  • Joseph LoscalzoDirectorNamed in SEC Form D filings
  • Michael RubinDirectorNamed in SEC Form D filings
  • Miklos KoborDirectorNamed in SEC Form D filings
  • REGINALD SEETOExecutive Officer, DirectorNamed in SEC Form D filings
  • SAMIR KAULDirectorNamed in SEC Form D filings
  • TIM ANDERSONDirectorNamed in SEC Form D filings
  • TODD SONEDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • ONCA BIO, INC.Similar federal contract value in Biotech · null in contracts
  • CYNVEC, LLCSimilar federal contract value in Biotech · null in contracts
  • PROTHERA BIOLOGICS, INC.Similar federal contract value in Biotech · null in contracts
  • GFREE BIO, LLCSimilar federal contract value in Biotech · null in contracts
  • Viewpoint Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
  • Kumquat BiosciencesSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .